# Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery

> **NCT00459979** · PHASE2 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Kidney Cancer

## Interventions

- **DRUG:** sunitinib malate
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00459979
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2011-03
- **Final completion:** 2013-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00459979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00459979, "Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00459979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*